Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Fort Wayne
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fort Wayne, IN

Studies commonly pay $75 to $4,500 per completed study

113 clinical trials are currently recruiting participants within 30 miles of Fort Wayne. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

113studies recruiting
2+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fort Wayne right now

Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Parkview Research Center at Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 710 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07022483)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0002) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Urothelial Cancer, Urinary Bladder Neoplasms Phase 3 Interventional 390 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07566156)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0011) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Small-cell Lung Cancer, Neuroendocrine Carcinomas Phase 1, Phase 2 Interventional 262 participants sought
Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office — Fort Wayne, Indiana (3.0 mi) · Sponsor: IDEAYA Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07174583)

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (CRC) Phase 3 Interventional 600 participants sought
Clinical Study Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: Summit Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07228832)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Parkview Research Center at Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06890598)

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 480 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06667076)

Manual Therapy, Exercise and US Vs. Manual Therapy, Exercise and US for Medial Epicondylalgia

Epicondylalgia N/A Interventional 110 participants sought
Mallers and Swoverland Orthopedic PT — Fort Wayne, Indiana (3.0 mi) · Sponsor: Alabama Physical Therapy & Acupuncture
See eligibility & contact on ClinicalTrials.gov (NCT04609735)

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Aortic Stenosis, Coronary Artery Disease N/A Interventional 4,000 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: University of British Columbia
See eligibility & contact on ClinicalTrials.gov (NCT04634240)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi) · Sponsor: OncoC4, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05671510)

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Focal Seizure, Epilepsy Phase 3 Interventional 333 participants sought
Indiana University Health Fort Wayne Neurology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Rapport Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07563881)

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma Phase 3 Interventional 49 participants sought
Study Site 101 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Grifols Biologicals, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07582432)

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Non Small Cell Lung Cancer, Triple Negative Breast Cancer Phase 1 Interventional 85 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Compass Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06150664)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)
Actively enrolling

Studies you may be able to join near Fort Wayne

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fort Wayne

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Salus Research

★ 5.0
1220 Medical Park Dr A, Fort Wayne, IN 46825
(260) 755-1099
"Best of everything! Ten stars out of five!!"
— Bruce Wilder, 5★

Avenues Recovery Center at Fort Wayne

★ 4.9 (957 reviews)
2626 Fairfield Ave, Fort Wayne, IN 46807
(260) 909-8343
"I chose Avenues Ft. Wayne and have not one time felt regret over the decision.<br>The beds here are comfortable.<br>The rooms and facilities are clea…"
— Jonathan Buuck, 5★

Clinical trials in Fort Wayne: what's recruiting

The Fort Wayne area currently has 113 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fort Wayne, the most active research areas are:

  • Cancer & Oncology19 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Fort Wayne, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fort Wayne

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fort Wayne participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fort Wayne pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fort Wayne?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Fort Wayne?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fort Wayne?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Wayne.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Wayne typically complete one or two studies per year.

Paid clinical trials near Fort Wayne

Other metros within reach

Elkhart, IN113 Kalamazoo, MI107 South Bend, IN113 Dayton, OH310 Indianapolis, IN913 Toledo, OH208 Lansing, MI183 Ann Arbor, MI1,186

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fort Wayne Bladder Issues Due To Spinal Cord Injury in Fort Wayne All conditions

More of IN

Indianapolis913 Elkhart113 South Bend113 Evansville68 Lafayette39

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts